Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
Top Cited Papers
Open Access
- 1 February 2001
- journal article
- review article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 107 (3), 241-246
- https://doi.org/10.1172/jci11991
Abstract
No abstract availableThis publication has 51 references indexed in Scilit:
- Paclitaxel sensitivity of breast cancer cells with constitutively active NF-κB is enhanced by IκBα super-repressor and parthenolideOncogene, 2000
- The NF-κB Signaling Pathway Is Not Required for Fas Ligand Gene Induction but Mediates Protection from Activation-induced Cell DeathPublished by Elsevier ,2000
- Role of NF-κB in p53-mediated programmed cell deathNature, 2000
- Control of apoptosis by Rel/NF-κB transcription factorsOncogene, 1999
- Aberrant rel/nfkb genes and activity in human cancerOncogene, 1999
- The Tax Oncoprotein of Human T-cell Leukemia Virus Type 1 Associates with and Persistently Activates IκB Kinases Containing IKKα and IKKβJournal of Biological Chemistry, 1998
- Phosphorylation of NF-κB p65 by PKA Stimulates Transcriptional Activity by Promoting a Novel Bivalent Interaction with the Coactivator CBP/p300Molecular Cell, 1998
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998
- The role of Rel/NF-κB proteins in viral oncogenesis and the regulation of viral transcriptionSeminars in Cancer Biology, 1997
- Constitutive expression of lymphoma-associated NFKB-2/Lyt-10 proteins is tumorigenic in murine fibroblastsOncogene, 1997